Allergan plc
AGN.PRA
AGN.PRA was delisted on the 28th of February, 2018.
106 hedge funds and large institutions have $2.91B invested in Allergan plc in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 42 increasing their positions, 30 reducing their positions, and 13 closing their positions.
40% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 30
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
10% more capital invested
Capital invested by funds: $2.65B → $2.91B (+$258M)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2% less funds holding
Funds holding: 108 → 106 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$532M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$86.1M |
| 3 |
O
OrbiMed
New York
|
+$73.1M |
| 4 |
SC
Sculptor Capital
New York
|
+$52.5M |
| 5 |
QF
QVT Financial
New York
|
+$41.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$45M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$38.1M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$32.8M |
| 4 |
CIC
Chilton Investment Company
Stamford,
Connecticut
|
-$31.1M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$24.4M |
AGN.PRA Hedge Fund Activity: Q1 2017 in Review
106 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN.PRA) for Q1 2017, worth a combined $2.91B — up 9.7% from $2.65B a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new AGN.PRA positions and 13 closed out — a net gain of 3 holders — while 42 added to existing stakes and 30 trimmed.
The largest buyer was BlackRock, adding an estimated $532M. The largest seller was Fidelity Investments, cutting an estimated $45M.
- 106 institutional investors held Allergan plc (AGN.PRA) as of Q1 2017, down from 108 in Q4 2016.
- Funds reported $2.91B of Allergan plc stock for Q1 2017, up 9.7% quarter-over-quarter.
- 16 funds opened new Allergan plc positions in Q1 2017 and 13 closed out, a net change of +3 holders.
- The largest Allergan plc buyer in Q1 2017 was BlackRock, an estimated $532M added.
- The largest Allergan plc seller in Q1 2017 was Fidelity Investments, an estimated $45M sold.
Based on aggregated 13F filings for Q1 2017.